Cargando…

Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study

OBJECTIVE: In Africa, the number of patients with hypertension is expected to reach 216.8 million by 2030. Large-scale data on antihypertensive medications used in Sub-Saharan Africa (SSA) are scarce. Here, we describe antihypertensive drug strategies and identify treatment factors associated with b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavagna, Pauline, Takombe, Jean Laurent, Damorou, Jean Marie, Kouam Kouam, Charles, Diop, Ibrahima Bara, Ikama, Stephane Méo, Kramoh, Kouadio Euloge, Ali Toure, Ibrahim, Balde, Dadhi, Dzudie, Anastase, Ferreira, Beatriz, Houenassi, Martin, Kane, Adama, Kimbally-kaki, Suzy Gisele, Kingue, Samuel, Limbole, Emmanuel, Mfeukeu Kuate, Liliane, Mipinda, Jean Bruno, N'Guetta, Roland, Nhavoto, Carol, Sidy Ali, Abdallahi, Gaye, Bamba, Tajeu, Gabriel S, Macquart De Terline, Diane, Perier, Marie Cécile, Azizi, Michel, Jouven, Xavier, Antignac, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640662/
https://www.ncbi.nlm.nih.gov/pubmed/34857562
http://dx.doi.org/10.1136/bmjopen-2021-049632
_version_ 1784609376686833664
author Cavagna, Pauline
Takombe, Jean Laurent
Damorou, Jean Marie
Kouam Kouam, Charles
Diop, Ibrahima Bara
Ikama, Stephane Méo
Kramoh, Kouadio Euloge
Ali Toure, Ibrahim
Balde, Dadhi
Dzudie, Anastase
Ferreira, Beatriz
Houenassi, Martin
Kane, Adama
Kimbally-kaki, Suzy Gisele
Kingue, Samuel
Limbole, Emmanuel
Mfeukeu Kuate, Liliane
Mipinda, Jean Bruno
N'Guetta, Roland
Nhavoto, Carol
Sidy Ali, Abdallahi
Gaye, Bamba
Tajeu, Gabriel S
Macquart De Terline, Diane
Perier, Marie Cécile
Azizi, Michel
Jouven, Xavier
Antignac, Marie
author_facet Cavagna, Pauline
Takombe, Jean Laurent
Damorou, Jean Marie
Kouam Kouam, Charles
Diop, Ibrahima Bara
Ikama, Stephane Méo
Kramoh, Kouadio Euloge
Ali Toure, Ibrahim
Balde, Dadhi
Dzudie, Anastase
Ferreira, Beatriz
Houenassi, Martin
Kane, Adama
Kimbally-kaki, Suzy Gisele
Kingue, Samuel
Limbole, Emmanuel
Mfeukeu Kuate, Liliane
Mipinda, Jean Bruno
N'Guetta, Roland
Nhavoto, Carol
Sidy Ali, Abdallahi
Gaye, Bamba
Tajeu, Gabriel S
Macquart De Terline, Diane
Perier, Marie Cécile
Azizi, Michel
Jouven, Xavier
Antignac, Marie
author_sort Cavagna, Pauline
collection PubMed
description OBJECTIVE: In Africa, the number of patients with hypertension is expected to reach 216.8 million by 2030. Large-scale data on antihypertensive medications used in Sub-Saharan Africa (SSA) are scarce. Here, we describe antihypertensive drug strategies and identify treatment factors associated with blood pressure (BP) control in 12 Sub-Saharan countries. SETTING: Outpatient consultations for hypertension in urban tertiary cardiology centres of 29 hospitals from 17 cities across 12 SSA countries between January 2014 and November 2015. PARTICIPANTS: Patients ≥18 years of age with hypertension were enrolled at any visit during outpatient consultations in the cardiology departments MAIN OUTCOME MEASURE: We collected BP levels, demographic characteristics and antihypertensive treatment use (including traditional medicine) of patients with hypertension attending outpatient visits. BP control was defined as seated office BP <140/90 mm Hg. We used logistic regression with a random effect on countries to assess factors of BP control. RESULTS: Overall, 2198 hypertensive patients were included and a total of 96.6% (n=2123) were on antihypertensive medications. Among treated patients, 653 (30.8%) patients received a monotherapy by calcium channel blocker (n=324, 49.6%), renin–angiotensin system blocker (RAS) (n=126, 19.3%) or diuretic (n=122, 18.7%). Two-drug strategies were prescribed in 927 (43.6%) patients including mainly diuretics and RAS (n=327, 42% of two-drug strategies). Prescriptions of three-drugs or more were used in 543 (25.6%) patients. Overall, among treated patients, 1630 (76.7%) had uncontrolled BP, of whom 462 (28.3%) had BP levels ≥180/110 mm Hg, mainly in those on monotherapy. After adjustment for sociodemographic factors, the use of traditional medicine was the only factor significantly associated with uncontrolled BP (OR 1.72 (1.19 to 2.49) p<0.01). CONCLUSION: Our study provided large-scale data on antihypertensive prescriptions in the African continent. Among patients declared adherent to drugs, poor BP control was significantly associated with the use of traditional medicine.
format Online
Article
Text
id pubmed-8640662
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86406622021-12-15 Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study Cavagna, Pauline Takombe, Jean Laurent Damorou, Jean Marie Kouam Kouam, Charles Diop, Ibrahima Bara Ikama, Stephane Méo Kramoh, Kouadio Euloge Ali Toure, Ibrahim Balde, Dadhi Dzudie, Anastase Ferreira, Beatriz Houenassi, Martin Kane, Adama Kimbally-kaki, Suzy Gisele Kingue, Samuel Limbole, Emmanuel Mfeukeu Kuate, Liliane Mipinda, Jean Bruno N'Guetta, Roland Nhavoto, Carol Sidy Ali, Abdallahi Gaye, Bamba Tajeu, Gabriel S Macquart De Terline, Diane Perier, Marie Cécile Azizi, Michel Jouven, Xavier Antignac, Marie BMJ Open Global Health OBJECTIVE: In Africa, the number of patients with hypertension is expected to reach 216.8 million by 2030. Large-scale data on antihypertensive medications used in Sub-Saharan Africa (SSA) are scarce. Here, we describe antihypertensive drug strategies and identify treatment factors associated with blood pressure (BP) control in 12 Sub-Saharan countries. SETTING: Outpatient consultations for hypertension in urban tertiary cardiology centres of 29 hospitals from 17 cities across 12 SSA countries between January 2014 and November 2015. PARTICIPANTS: Patients ≥18 years of age with hypertension were enrolled at any visit during outpatient consultations in the cardiology departments MAIN OUTCOME MEASURE: We collected BP levels, demographic characteristics and antihypertensive treatment use (including traditional medicine) of patients with hypertension attending outpatient visits. BP control was defined as seated office BP <140/90 mm Hg. We used logistic regression with a random effect on countries to assess factors of BP control. RESULTS: Overall, 2198 hypertensive patients were included and a total of 96.6% (n=2123) were on antihypertensive medications. Among treated patients, 653 (30.8%) patients received a monotherapy by calcium channel blocker (n=324, 49.6%), renin–angiotensin system blocker (RAS) (n=126, 19.3%) or diuretic (n=122, 18.7%). Two-drug strategies were prescribed in 927 (43.6%) patients including mainly diuretics and RAS (n=327, 42% of two-drug strategies). Prescriptions of three-drugs or more were used in 543 (25.6%) patients. Overall, among treated patients, 1630 (76.7%) had uncontrolled BP, of whom 462 (28.3%) had BP levels ≥180/110 mm Hg, mainly in those on monotherapy. After adjustment for sociodemographic factors, the use of traditional medicine was the only factor significantly associated with uncontrolled BP (OR 1.72 (1.19 to 2.49) p<0.01). CONCLUSION: Our study provided large-scale data on antihypertensive prescriptions in the African continent. Among patients declared adherent to drugs, poor BP control was significantly associated with the use of traditional medicine. BMJ Publishing Group 2021-12-02 /pmc/articles/PMC8640662/ /pubmed/34857562 http://dx.doi.org/10.1136/bmjopen-2021-049632 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Global Health
Cavagna, Pauline
Takombe, Jean Laurent
Damorou, Jean Marie
Kouam Kouam, Charles
Diop, Ibrahima Bara
Ikama, Stephane Méo
Kramoh, Kouadio Euloge
Ali Toure, Ibrahim
Balde, Dadhi
Dzudie, Anastase
Ferreira, Beatriz
Houenassi, Martin
Kane, Adama
Kimbally-kaki, Suzy Gisele
Kingue, Samuel
Limbole, Emmanuel
Mfeukeu Kuate, Liliane
Mipinda, Jean Bruno
N'Guetta, Roland
Nhavoto, Carol
Sidy Ali, Abdallahi
Gaye, Bamba
Tajeu, Gabriel S
Macquart De Terline, Diane
Perier, Marie Cécile
Azizi, Michel
Jouven, Xavier
Antignac, Marie
Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study
title Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study
title_full Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study
title_fullStr Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study
title_full_unstemmed Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study
title_short Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study
title_sort blood pressure-lowering medicines implemented in 12 african countries: the cross-sectional multination eight study
topic Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640662/
https://www.ncbi.nlm.nih.gov/pubmed/34857562
http://dx.doi.org/10.1136/bmjopen-2021-049632
work_keys_str_mv AT cavagnapauline bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT takombejeanlaurent bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT damoroujeanmarie bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT kouamkouamcharles bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT diopibrahimabara bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT ikamastephanemeo bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT kramohkouadioeuloge bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT alitoureibrahim bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT baldedadhi bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT dzudieanastase bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT ferreirabeatriz bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT houenassimartin bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT kaneadama bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT kimballykakisuzygisele bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT kinguesamuel bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT limboleemmanuel bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT mfeukeukuateliliane bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT mipindajeanbruno bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT nguettaroland bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT nhavotocarol bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT sidyaliabdallahi bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT gayebamba bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT tajeugabriels bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT macquartdeterlinediane bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT periermariececile bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT azizimichel bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT jouvenxavier bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy
AT antignacmarie bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy